Enliven Therapeutics, Inc. (ELVN) insider trading.
In Q3 2026, insiders at Enliven Therapeutics, Inc. reported 32 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 23 sales worth $11.8M.
- Transactions
- 32
- Purchases (P)
- 0
- Sales (S)
- 23
- Net shares, P minus S
- -201,849
- Insiders
- 4
- Last filed
- 2026-09-21
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Collins Helen Louise | Officer · CHIEF MEDICAL OFFICER | 13 | 0 | 10 |
| Hohl Benjamin | Officer · CHIEF FINANCIAL OFFICER | 12 | 0 | 10 |
| Derynck Mika K | Director | 5 | 0 | 1 |
| Kunkel Lori Anne | Director | 2 | 0 | 2 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | Collins Helen Louise | S (D) | 1,844 | $50.71 | 25,240 | Form 4 |
| 2026-09-17 | Collins Helen Louise | S (D) | 2,916 | $50.03 | 27,084 | Form 4 |
| 2026-09-17 | Collins Helen Louise | M (A) | 5,000 | $2.48 | 30,000 | Form 4 |
| 2026-09-17 | Collins Helen Louise | S (D) | 240 | $51.48 | 25,000 | Form 4 |
| 2026-09-17 | Hohl Benjamin | M (A) | 3,982 | $14.85 | 44,018 | Form 4 |
| 2026-09-17 | Hohl Benjamin | S (D) | 3,535 | $50.03 | 40,483 | Form 4 |
| 2026-09-17 | Hohl Benjamin | S (D) | 2,194 | $50.72 | 38,289 | Form 4 |
| 2026-09-17 | Hohl Benjamin | S (D) | 289 | $51.49 | 38,000 | Form 4 |
| 2026-08-17 | Collins Helen Louise | S (D) | 3,900 | $58.37 | 26,100 | Form 4 |
| 2026-08-17 | Collins Helen Louise | M (A) | 5,000 | $2.48 | 30,000 | Form 4 |
| 2026-08-17 | Collins Helen Louise | S (D) | 1,100 | $59.35 | 25,000 | Form 4 |
| 2026-08-17 | Hohl Benjamin | S (D) | 4,630 | $58.35 | 41,424 | Form 4 |
| 2026-08-17 | Hohl Benjamin | S (D) | 1,388 | $59.35 | 40,036 | Form 4 |
| 2026-08-04 | Derynck Mika K | S (D) | 158,795 | $60.21 | 0 | Form 4 |
| 2026-08-04 | Derynck Mika K | M (A) | 20,491 | $22.47 | 158,795 | Form 4 |
| 2026-08-04 | Derynck Mika K | M (A) | 23,364 | $14.85 | 138,304 | Form 4 |
| 2026-08-04 | Derynck Mika K | M (A) | 27,567 | $25.28 | 114,940 | Form 4 |
| 2026-08-04 | Derynck Mika K | M (A) | 87,373 | $2.48 | 87,373 | Form 4 |
| 2026-07-17 | Collins Helen Louise | S (D) | 2,063 | $52.39 | 27,247 | Form 4 |
| 2026-07-17 | Collins Helen Louise | S (D) | 2,184 | $53.42 | 25,063 | Form 4 |
| 2026-07-17 | Collins Helen Louise | S (D) | 63 | $53.92 | 25,000 | Form 4 |
| 2026-07-17 | Collins Helen Louise | M (A) | 5,000 | $2.48 | 30,000 | Form 4 |
| 2026-07-17 | Collins Helen Louise | S (D) | 231 | $50.05 | 29,769 | Form 4 |
| 2026-07-17 | Collins Helen Louise | S (D) | 459 | $51.55 | 29,310 | Form 4 |
| 2026-07-17 | Hohl Benjamin | S (D) | 123 | $53.87 | 46,054 | Form 4 |
| 2026-07-17 | Hohl Benjamin | S (D) | 2,638 | $53.38 | 46,177 | Form 4 |
| 2026-07-17 | Hohl Benjamin | M (A) | 1,072 | $2.48 | 52,072 | Form 4 |
| 2026-07-17 | Hohl Benjamin | S (D) | 324 | $49.97 | 51,748 | Form 4 |
| 2026-07-17 | Hohl Benjamin | S (D) | 369 | $51.48 | 51,379 | Form 4 |
| 2026-07-17 | Hohl Benjamin | S (D) | 2,564 | $52.32 | 48,815 | Form 4 |
| 2026-07-06 | Kunkel Lori Anne | S (D) | 5,889 | $50.84 | 41,884 | Form 4 |
| 2026-07-06 | Kunkel Lori Anne | S (D) | 4,111 | $49.98 | 47,773 | Form 4 |
Transaction codes in this quarter
Get ELVN insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1672619&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ELVN company page · Enliven Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Enliven Therapeutics, Inc. (ELVN)?
In Q3 2026, insiders at Enliven Therapeutics, Inc. reported 32 non-derivative transactions on 8 Forms 3, 4 and 5: 0 open-market purchases and 23 sales worth $11.8M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Enliven Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/elvn.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.